{
}
Deutsche Bank's Annual General Meeting (AGM) on May 22, 2025, will propose a 50% dividend increase to €0.68 per share for 2024, alongside a share repurchase program of €750 million. New Supervisory Board members Kirsty Roth and Klaus Moosmayer will succeed Dagmar Valcárcel and Theodor Weimer, who are stepping down. The AGM will feature expanded participation options, allowing shareholders to submit questions live via video.
US markets are under pressure as fears of a trade war escalate with President Trump's impending tariffs affecting all countries. The Dow Jones and Nasdaq 100 indices have seen significant declines, while gold prices soar amid geopolitical tensions. Vaccine stocks also suffered, with Moderna and Biontech experiencing sharp losses.
The Dimensional International Value ETF (DFIV) has seen a significant inflow of approximately $204.5 million, marking a 2.1% increase in outstanding units. Key components include Shell plc (up 0.2%), HSBC Holdings plc (down 0.4%), and Novartis (up 1.3%). DFIV's current share price is $40.05, within a 52-week range of $34.03 to $40.90.
With low interest rates likely to persist, the stock market is poised for growth as companies can borrow cheaply to invest. However, geopolitical tensions and uncertainties may lead to volatility in 2025, making high-dividend stocks a safer investment choice for stable returns. The Swiss equity market, known for its defensive nature, features companies like Nestlé and Roche that offer attractive dividends, providing a buffer against market fluctuations.
Swiss pharmaceutical giants Roche and Novartis have abandoned their diversity, equity, and inclusion (DEI) targets in the USA, following new political guidelines from the Trump administration that label such measures as "illegal and wasteful." Roche has informed its global workforce that DEI targets will no longer be publicly communicated, while UBS has removed DEI references from its reports. Other Swiss firms like ABB and Nestlé are currently maintaining a low profile but may adjust their policies based on local conditions.
UBS is contemplating leaving Switzerland, raising concerns about the implications for its identity and the country's reputation. The potential removal of "Switzerland" from its name reflects broader unease regarding the bank's relationship with Swiss citizens and politicians, especially in light of recent financial mismanagement exemplified by Credit Suisse. As UBS weighs its options, the question remains: what value does Switzerland hold for a global financial institution?
Morgan Stanley analyst Judah Frommer highlights that Novartis' Fabhalta has received FDA approval for C3G, but its restricted label leaves room for Apellis' Empaveli to stand out. Fabhalta is indicated for adults to reduce proteinuria, with no established outcomes for post-transplant patients. The firm believes Empaveli can lead in C3G/IC-MPGN, projecting peak U.S. revenue of $550M if its sNDA is approved, contributing $12 to Apellis' $30 price target.
The Swiss stock market remained positive following the Swiss National Bank's decision to cut its key interest rate by 25 basis points to 0.25%. Analysts expect this to be the last cut for the year, with inflation forecasts suggesting no need for further reductions. The SMI index rose by 0.11%, led by Nestlé, while Swissquote shares fell by 7.7% despite reporting a strong fiscal performance.
The Swiss stock market remained positive as the Swiss National Bank (SNB) cut its key interest rate by 25 basis points to 0.25%, a move anticipated by analysts. The SMI index rose by 0.11%, led by Nestlé and Alcon, while Swissquote shares fell 7.7% despite reporting a strong fiscal performance. HOCN shares surged 19% amid plans to appeal a delisting decision.
Roche has abandoned its global diversity targets, including a female management quota of nearly 38% and a goal of employing 19% ethnic minorities, in response to new US regulations. This decision follows similar moves by Novartis and UBS, as companies adapt to the Trump administration's stance against diversity programs. Despite this shift, Roche emphasizes its commitment to fostering an inclusive work environment.
Novartis AG
Companies
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
deutsche bank announces new supervisory board members and dividend increase for 2024
Euro
Novartis AG
Credit Suisse Strategic Income I
Siemens AG
Thomson Reuters Corporation
Deutsche Bank Money Market PP
DEU
Alexander Wynaendts
Kirsty Roth
Klaus Moosmayer
Frank Witter
Theodor Weimer
Sigmar Gabriel
Christian Sewing
Show more
15:53 31.03.2025
us markets decline amid tariff fears and geopolitical tensions as gold surges
Russian Ruble
Swiss Franc
United States Dollar
Euro
Iranian Rial
Amazon.com, Inc.
Novartis AG
Wolfspeed, Inc.
ABB Ltd
Axon Partners Group, S.A.
Nestle SA
Tesla, Inc.
Apple Inc.
Moderna, Inc.
Implenia AG
BioNTech SE
lululemon athletica inc.
NVIDIA Corporation
Logitech International S.A.
Alphabet Inc.
RICHEMONT, Intellectual Property Services
London Stock Exchange Group plc
Akademiska Hus AB
Microsoft Corporation
Robert F. Kennedy Jr.
Edward Yardeni
Donald Trump
Kevin Hassett
Show more
07:17 31.03.2025
dimensional international value etf sees significant inflow and notable stock movements
17:06 27.03.2025
stable income through high dividend stocks in uncertain markets
United States Dollar
S Tempo Swiss Life AM
Novartis AG
Swiss Re AG
Zurich, Agence générale Christian Meier SA
Hoffmann-La Roche AG
Nestlé S.A.
CHE
Jean Rochefort
Show more
11:10 27.03.2025
Swiss companies abandon diversity targets in the United States
United States Dollar
Novartis AG
Hoffmann-La Roche AG
ABB Ltd
Nestlé S.A.
USA
CHE
Nicole Niedermann
Rebekka Schnell
Show more
11:00 24.03.2025
UBS Considers Leaving Switzerland Amid Growing Political and Tax Concerns
23:58 22.03.2025
Morgan Stanley highlights Empaveli's potential amid Fabhalta's FDA approval for C3G
16:41 22.03.2025
swiss stock market remains positive after snb interest rate cut
Swiss Franc
Novartis AG
Swissquote Group Holding Ltd
Nestlé S.A.
Julius Bär Gruppe AG
Holcim AG
Alcon Inc.
Hoffmann-La Roche AG
Adecco Group AG
RICHEMONT, Intellectual Property Services
The Swatch Group AG
Sonova R
Axon Partners Group, S.A.
Sandoz Group AG
CHE
Arthur Jurus
Karsten Junius
Philipp Merkt
Show more
11:36 20.03.2025
Swiss stock market remains positive after SNB interest rate cut
Swiss Franc
Novartis AG
Swissquote Group Holding Ltd
Nestlé S.A.
Hocn AG
Holcim AG
Alcon Inc.
Hoffmann-La Roche AG
Adecco Group AG
RICHEMONT, Intellectual Property Services
The Swatch Group AG
Sonova R
Axon Partners Group, S.A.
Sandoz Group AG
CHE
Arthur Jurus
Karsten Junius
Philipp Merkt
Show more
11:35 20.03.2025
Roche abandons global diversity targets amid changing US regulations
13:03 19.03.2025
Trending
Subcategory
Countries:
Companies:
Currencies:
People: